Pendapatan dodolan perusahaan Lipella Pharmaceuticals, Inc. (LIPO)
Product sales for Lipella Pharmaceuticals demonstrate volatility, where the 0.00 mark records this metric, highlighting the business's dependence on venture capital and the risks of test failures. Meanwhile, the company adheres to basic environmental standards in its laboratories. The competitive advantage of Lipella Pharmaceuticals lies in its local drug delivery method for the therapy of rare bladder pathologies.
%20Pendapatan%20perusahaan&width=1200&height=400&colorIndex=0&v=mwhdatcg.m7-7dqbc3k&start=20220704&end=20261115&filename=GURU_Markets_-_LIPO_-_Lipella-Pharmaceuticals_-_Company-Revenue "Lipella Pharmaceuticals Inc (LIPO): Pendapatan perusahaan saka 28.04.2023 nganti 19.07.2025 | 👁️GURU.Markets👁️")
Rincian metrik komprehensif lan analitis lipella.com (LIPO)
- rega pasar lan target rega analis:
- rincian kapitalisasi pasar:
- indikator nilai aset resik miturut neraca:
- data liabilitas lan likuiditas perusahaan:
Utang Agregat marang Ekuitas Lipella Pharmaceuticals|LIPO - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Lipella Pharma|LIPO - Utang perusahaan|Rasio utang marang kapitalisasi buku Lipella|LIPO - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Lipella Pharmaceuticals|Rasio cepet lipella.com
- statistik bathi lan rasio pasar:
LIPO - Penghasilan resik|Penghasilan resik sing dikarepake Lipella Pharmaceuticals|LIPO - Rasio rega marang bathi|Rasio rega marang bathi sing dikarepake Lipella Pharmaceuticals, Inc.|LIPO - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan Lipella Pharmaceuticals Inc|LIPO - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Lipella Pharmaceuticals|LIPO - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan lipella.com|LIPO - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Lipella Pharmaceuticals
- statistik dodolan lan pendapatan perusahaan:
Analisis komprehensif perusahaan:lipella.com
The scale of Lipella Pharmaceuticals commercial operations is reflected in this sales time series, where the current value of 0.00 serves as a marker of operational efficiency. This indicator captures daily revenue dynamics to identify hidden payment delays, which is critical given the narrow development portfolio and the business's reliance on secondary offerings amid clinical trial uncertainty.
Analisis perusahaan pesaing
HLN: Pendapatan dodolan perusahaan|Pendapatan perusahaan Kenvue (KVUE)|VRNA (Verona Pharma Corp) - Pendapatan dodolan perusahaan|Pendapatan perusahaan Jyong Biotech MENS|Ligand Pharma - Pendapatan perusahaan|AMRX - Pendapatan perusahaan|Total pendapatan perusahaan perrigo.com|ALVO (Alvotech SA) - Dodolan perusahaan|Total volume dodolan perusahaan Liquidia Technologies LQDA|GLPG (Galapagos N.V.) - Pendapatan lan volume dodolan|ANIP: Pendapatan dodolan perusahaan|Pendapatan perusahaan Afrezza (MNKD)|Pendapatan lan volume dodolan amphastar.com (AMPH)|Pendapatan lan volume dodolan PCRX (pacira.com)|Pendapatan dodolan perusahaan SPRY|Theravance Biopharma Inc - Pendapatan lan volume dodolan|Pendapatan reged perusahaan Aquestive Therapeutics AQST|SCPH: Pendapatan lan volume dodolan|Dodolan perusahaan Tectonic Therapeutic, Inc.|TNXP (tonixpharma.com) - Pendapatan lan volume dodolan|SXTC (China SXT Pharmaceuticals, Inc.) - Total dodolan perusahaan|Pendapatan perusahaan eupraxiapharma.com (EPRX)|Total dodolan perusahaan BHST|Pendapatan perusahaan eXoZymes EXOZ|Pendapatan dodolan perusahaan ORMP|ENTX - Pendapatan perusahaan|HYFT: Pendapatan perusahaan|ABVC BioPharma, Inc (ABVC) - Pendapatan perusahaan|Cumberland Pharma - Pendapatan dodolan perusahaan|QNTM (Quantum BioPharma Corp) - Pendapatan lan volume dodolan|FibroGen, Inc. - Pendapatan tahunan perusahaan|Pendapatan lan volume dodolan TELO|Pendapatan reged perusahaan Rani Therapeutics Holdings, Inc.|Pendapatan perusahaan Synergy CHC Corp. SNYR|Pendapatan lan volume dodolan rallybio.com RLYB|Lexaria Bioscience Corp. - Pendapatan lan volume dodolan|PULM: Pendapatan perusahaan|PTHL (ftzy.com.cn) - Dodolan perusahaan|APM: Total dodolan perusahaan|LYRA (Lyra Therapeutics Inc) - Pendapatan lan volume dodolan|Volume dodolan perusahaan IBO (Impact BioMedical)|Dodolan perusahaan TNFA (TNF Pharmaceuticals)|Pendapatan lan volume dodolan cbdMD Corp (YCBD)|Pendapatan lan volume dodolan PRFX (PainReform)|Pendapatan reged perusahaan Auris Medical (CYTO)|OPTN - Pendapatan perusahaan|Pendapatan reged perusahaan Pieris Pharma PIRS|Procaps Group SA (PROC) - Pendapatan perusahaan|Pendapatan tahunan perusahaan PTPI (Petros Pharmaceuticals, Inc.)|QLI (Qilian International Holding) - Pendapatan lan volume dodolan|SLRN: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan TFFP
